Regulation of NKT cell development by SAP, the protein defective in XLP

Nature Medicine

Volumn 11, Issue 3, 2005, Pages 340-345

  Nichols, Kim E ^a,b   Hom, Jamie ^b   Gong, Shun You ^c   Ganguly, Arupa ^c   Ma, Cindy S ^d   Cannons, Jennifer L ^e   Tangye, Stuart G ^d   Schwartzberg, Pamela L ^e   Koretzky, Gary A ^b,c   Stein, Paul L ^c,f  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d CENTENARY INSTITUTE   (Australia)

^e NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ALPHA GALACTOSYLCERAMIDE; DNA; GAMMA INTERFERON; INTERLEUKIN 4; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN;

ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; EPSTEIN BARR VIRUS; GENE LOCUS; HUMAN; HUMAN CELL; HYPOGAMMAGLOBULINEMIA; IMMUNOREGULATION; LYMPHOCYTE; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; ONTOGENY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; T LYMPHOCYTE; TUMOR IMMUNITY; VIRUS INFECTION; X CHROMOSOME INACTIVATION; X CHROMOSOME LINKED DISORDER; X LINKED LYMPHOPROLIFERATIVE DISEASE;

ANIMALS; CHROMOSOMES, HUMAN, X; CYTOKINES; DOSAGE COMPENSATION, GENETIC; FEMALE; GENETIC DISEASES, X-LINKED; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; LYMPHOPROLIFERATIVE DISORDERS; MICE; T-LYMPHOCYTES;

EID: 20144387328     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1189     Document Type: Article

References (30)

1. Latour, S. & Veillette, A. Molecular and immunological basis of X-linked lymphoproliferative disease. Immunol. Rev. 192, 212-224 (2003).
2. Sharifi, R. et al. SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease. Blood 103, 3821-3827 (2004).
3. H2 differentiation and PKC-θ-mediated activation of NF-κB1. Immunity 21, 693-706 (2004).
4. Kronenberg, M. & Gapin, L. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2, 557-568 (2002).
5. Coffey, A.J. et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 20, 129-135 (1998).
6. Nichols, K.E. et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl. Acad. Sci. USA 95, 13765-13770 (1998).
7. Sayos, J. et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395, 462-469 (1998).
8. Schuster, V. & Kreth, H.W. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein. Immunol. Rev. 178, 21-28 (2000).
9. H2 cells. Nat. Immunol. 2, 410-414 (2001).
10. Czar, M.J. et al. Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP. Proc. Natl. Acad. Sci. USA 98, 7449-7454 (2001).
11. + T cells occurring in association with elevated EBV loads in XLP patients surviving primary EBV infection. Blood 103, 1625-1631 (2004).
12. Yin, L. et al. Mice deficient in the X-linked lymphoproliferative disease gene sap exhibit increased susceptibility to murine gamma-herpesvirus-68 and hypogammaglobulinemia. J. Med. Virol. 71, 446-455 (2003).
13. Hron, J.D., Caplan, L., Gerth, A.J., Schwartzberg, P.L. & Peng, S.L. SH2D1A regulates T-dependent humoral autoimmunity. J. Exp. Med. 200, 261-266 (2004).
14. Crotty, S., Kersh, E.N., Cannons, J., Schwartzberg, P.L. & Ahmed, R. SAP is required for generating long-term humoral immunity. Nature 421, 282-287 (2003).
15. Purtilo, D.T. et al. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1, 935-941 (1975).
16. Seemayer, T.A. et al. X-linked Lymphoproliferative Disease. In Infectious Causes of Cancer, Targets for Intervention (ed. Goedert, J.J.) 51-61 (Humana Press, Totowa, 2000).
17. Latour, S. et al. Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signaling in immune regulation. Nat. Cell. Biol. 5, 149-154 (2003).
18. Gadue, P., Morton, N. & Stein, P.L. The Src family tyrosine kinase Fyn regulates natural killer T cell development. J. Exp. Med. 190, 1189-1196 (1999).
19. Eberl, G., Lowin-Kropf, B. & MacDonald, H.R. Cutting edge: NKT cell development is selectively impaired in Fyn-deficient mice. J. Immunol. 163, 4091-4094 (1999).
20. Carnaud, C. et al. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163, 4647-4650 (1999).
21. + T cell development and early IL-4 production in CD1-deficient mice. Immunity 6, 459-467 (1997).
22. Mendiratta, S.K. et al. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6, 469-477 (1997).
23. Smiley, S.T., Kaplan, M.H. & Grusby, M.J. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 275, 977-979 (1997).
24. Wengler, G.S. et al. A PCR-based non-radioactive X-chromosome inactivation assay for genetic counseling in X-linked primary immunodeficiencies. Life Sci. 61, 1405-1411 (1997).
25. Wang, N. et al. The cell surface receptor SLAM controls T cell and macrophage functions. J. Exp. Med. 199, 1255-1264 (2004).
26. Roberts, T.J., Lin, Y., Spence, P.M., Van Kaer, L. & Brutkiewicz, R.R. CD1d1-dependent control of the magnitude of an acute antiviral immune response. J. Immunol. 172, 3454-3461 (2004).
27. Smyth, M.J. et al. NKT cells - conductors of tumor immunity? Curr. Opin. Immunol. 14, 165-171 (2002).
28. Galli, G. et al. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J. Exp. Med. 197, 1051-1057 (2003).
29. fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell 10, 741-750 (1992).
30. Pear, W.S. et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 92, 3780-3792 (1998).